ClinicalTrials.Veeva

Menu

Intestinal Biomarker Analysis After ECP for ICI Colitis (IBA_ECP)

U

University of Freiburg

Status

Completed

Conditions

Immune Checkpoint Inhibitor-Related Colitis
Colitis

Treatments

Other: Intestinal tissue analysis

Study type

Observational

Funder types

Other

Identifiers

NCT06074874
ICI_colitis_ECP

Details and patient eligibility

About

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the chnages of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

Full description

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the changes of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICI colitis

Exclusion criteria

  • no informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Robert Zeiser, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems